BioSpace News Archive

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the data on the intravenous (IV) formulation of NEPA (Akynzeo®) will be presented as poster at the American Society of Clinical Oncology (ASCO) Congress in June 2019 on the poster session Symptoms and Survivorship.

BGI Americas, a leading genomic services company, announced today at the American Society of Mass Spectrometry conference (ASMS) that it has opened a state-of-the-art Mass Spectrometry Center at its research facility in San Jose, California.

Veloxis Pharmaceuticals announced that the Company’s product, Envarsus XR, will be the subject of two oral and fifteen poster presentations at the American Transplant Congress June 1st-5th, 2019 in Boston, Massachusetts, USA.

Sihuan Pharmaceutical Holdings Group Ltd. the largest cardio-cerebral vascular drug manufacturer in China’s prescription drug market, announced that the Group has completed the post-launch clinical trials of “Cinepazide Maleate Injection” for the treatment of acute ischemic stroke.

Congenital heart disease occurs in up to 1 percent of live births, and the affected infants may require multiple surgeries, life-long medication, or heart transplants. In many patients, the exact cause of congenital heart disease is unknown.

CancerCare® has announced the publication of a patient manifesto, declaring the fundamental importance of including patients’ values and priorities in cancer treatment planning.

Today, the Biotechnology Institute announced the winner of the BioSTEM Leader Award, who will be recognized next week at the 2019 BIO International Convention in Philadelphia.

The global cancer stem cell therapeutics market is expected to post a CAGR of close to 11% during the period 2019-2023, according to the latest market research report by Technavio.

This year, Shanghai is offering a special “spot” for a family day out - CHINA AID 2019, organized by Shanghai Intex Exhibition Co., Ltd. - a unique experience of a show that integrates showcases, demonstrations and displays on cognition, education, health, family affection and leisure.

Bradley P. Gilbert, MD, MPP, Chief Executive Officer of Inland Empire Health Plan (IEHP), received Loma Linda University Health’s Meritorious Service Award during its annual commencement ceremony.